MedTrace Logo

Effects of 5-Aminolevulinic Acid on Glucose Metabolism

NCT01610778 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2013-12-19

No results posted yet for this study

Summary

This study is designed to evaluate efficacy of 5-aminolevulinic acid in subjects with type 2 diabetes on medication.

Conditions

  • Type 2 Diabetes on Medication

Interventions

DIETARY_SUPPLEMENT

Placebo

DIETARY_SUPPLEMENT

5-aminolevulinic acid phosphate

Sponsors & Collaborators

  • SBI Pharmaceuticals Co, Ltd.

    collaborator INDUSTRY

  • Hiroshima University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01610778 on ClinicalTrials.gov